Adding Anktiva to BCG led to better responses than BCG alone in people with high-risk bladder cancer who had not yet received BCG, the company said.
|Articles|December 1, 2022
Becoming A Patient Advocate
Advertisement
Being a part of a breast cancer community might drive some of us to become patient advocates. Being a patient advocate can be challenging, but it is also very rewarding. Continue reading this article as Rod Richie explains his advocacy story and what it takes to be a patient advocate.
Advertisement
Related to this article
An Ohio State hematologist explains how she weighs chemotherapy against targeted drugs, what side effects patients should expect and why learning about this specific leukemia matters.
Leanne Citrone shares how a BRCA mutation, an elective mastectomy and a stage 2C ovarian cancer diagnosis shaped her outlook, anxiety and advice to others.
A colon cancer survivor who cared for her mother with lung cancer shares how she learned to speak up, plus tips for advocating for yourself or a loved one.
Medicare's Part D out-of-pocket cap rises to $2,400 in 2027. Here is what that means for people taking costly oral cancer drugs, how the monthly payment plan works with it and what to check before open enrollment ends Dec. 7.
Ohio State hematologist Dr. Kerry Rogers says chemotherapy and newer targeted drugs both work well, and the right choice depends on the patient.
Given an 18-month prognosis for peritoneal mesothelioma in 2007, a mother shares the joy of tapping her son out at his Air Force basic training graduation.
A once-daily oral pill gives patients with symptomatic TGCT another option when surgery could cause more harm than good.
Advertisement
Advertisement
Trending on CURE
1
Patient Advocacy Advice From a Colon Cancer Survivor
2
Medicare Part D 2027: What a $2,400 Cap Means for Cancer Drugs
3
Living With BRCA and Ovarian Cancer: Leanne Citrone's Story
4
Inside the Clinic: How One Hematologist Approaches a Rare Leukemia
5